Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis

NCT00413699 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00413699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
February 5, 2007
Completion date
October 26, 2017
Enrollment
4,488 (actual)
Sites
469

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid